TLDR Nike, StockX settle NFT trademark feud, avoiding courtroom showdown. Sneaker NFTs spark legal clarity as Nike, StockX end lawsuit early. Nike wins key point; StockX settles to dodge full NFT trial risk. NFTs as trademarks? Nike’s lawsuit forces platforms to rethink tokens. Digital sneaker wars end quietly, but reshape NFT legal boundaries. Nike and [...] The post Nike and StockX Resolve NFT Trademark Fight with Settlement appeared first on CoinCentral.TLDR Nike, StockX settle NFT trademark feud, avoiding courtroom showdown. Sneaker NFTs spark legal clarity as Nike, StockX end lawsuit early. Nike wins key point; StockX settles to dodge full NFT trial risk. NFTs as trademarks? Nike’s lawsuit forces platforms to rethink tokens. Digital sneaker wars end quietly, but reshape NFT legal boundaries. Nike and [...] The post Nike and StockX Resolve NFT Trademark Fight with Settlement appeared first on CoinCentral.

Nike and StockX Resolve NFT Trademark Fight with Settlement

TLDR

  • Nike, StockX settle NFT trademark feud, avoiding courtroom showdown.
  • Sneaker NFTs spark legal clarity as Nike, StockX end lawsuit early.
  • Nike wins key point; StockX settles to dodge full NFT trial risk.
  • NFTs as trademarks? Nike’s lawsuit forces platforms to rethink tokens.
  • Digital sneaker wars end quietly, but reshape NFT legal boundaries.

Nike and StockX have ended their three-year legal battle over trademark use in sneaker-linked NFTs. The agreement stops a jury trial previously scheduled for October and dismisses all claims with prejudice. This NFT trademark fight marks a major turning point in how intellectual property intersects with blockchain assets.

Lawsuit Ends Without a Jury Verdict

Nike filed the lawsuit in February 2022, accusing StockX of infringing on its trademarks through Vault NFTs. The tokens featured images of Nike sneakers, allegedly misleading customers about Nike’s involvement. StockX denied wrongdoing, stating the NFTs only served as proof of ownership for real sneakers.

Nike escalated its complaint in May 2022 by alleging that StockX sold counterfeit sneakers on its platform. The allegations gained strength in March 2025 when the court ruled in Nike’s favor on part of the case. StockX was found liable for selling several fake Nike sneakers to undercover buyers.

The court scheduled the unresolved claims for trial, but both parties agreed to settle in late August 2025. Thus, the NFT trademark fight avoided a public courtroom showdown, protecting both companies from reputational and legal risks.

The key issue was whether NFTs qualify as “goods” under the Lanham Act. In 2025, the US Ninth Circuit confirmed that NFTs linked to physical items fall under trademark protection. This ruling aligned with Nike’s claims and shaped the broader outcome of this NFT trademark fight.

StockX had argued that its Vault NFTs only tracked ownership, not brand affiliation. However, Nike maintained that unauthorized use of sneaker images diluted its brand. The settlement ended this standoff without a ruling on the full scope of NFT liability.

This case adds to the growing legal clarity around NFTs and trademark rights. Platforms now face stricter guidelines when tying tokens to branded physical goods. The NFT trademark fight made companies reconsider how they handle digital and IP assets together.

Industry Impact and RTFKT Shutdown

The lawsuit’s outcome echoes across the NFT and sneaker sectors. In December 2024, Nike shut down its digital studio RTFKT, citing a shift in strategy. The closure followed legal concerns and marked a retreat from experimental NFT ventures.

RTFKT had gained attention for combining NFTs with real sneakers, including partnerships with artists and Ethereum-based drops. However, operational and legal challenges led Nike to fold the studio’s services. That decision signaled declining tolerance for loosely regulated digital platforms.

The NFT trademark fight also impacted marketplaces’ handling of counterfeit risks. StockX’s 2025 Brand Protection Report said it blocked $10 million in fake shoes using RFID and CT scans. These changes suggest platforms will use tech to avoid future legal disputes.

The fight also affected funding trends. In 2025, firms raised $4.2 billion for environmentally friendly NFTs with verified supply chains. The NFT trademark fight forced investors and companies to align digital assets with strong compliance standards.

The post Nike and StockX Resolve NFT Trademark Fight with Settlement appeared first on CoinCentral.

Market Opportunity
AINFT Logo
AINFT Price(NFT)
$0.0000003642
$0.0000003642$0.0000003642
+0.24%
USD
AINFT (NFT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23